Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Location
Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
Telephone Numbers
Customer Service: (800) 227-6666 / (650) 697-3600
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G145846-50 | 50 µg | $463 |
| LS-G145846-500 | 500 µg | $2,353 |
Coronavirus SARS-CoV-2 Spike Glycoprotein (Recombinant mFc, C-terminus) (Arg319-Pro589) - LS-G145846
Coronavirus SARS-CoV-2 Spike Glycoprotein (Recombinant mFc, C-terminus) (Arg319-Pro589) - LS-G145846
Description:
SARS-CoV-2 Spike Glycoprotein LS-G145846 is a Recombinant Coronavirus SARS-CoV-2 Spike Glycoprotein produced in Mammalian Arg319-Pro589 with mFc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method).
Toll Free North America
(800) 227-6666
(800) 227-6666For Research Use Only
Overview
Description:
SARS-CoV-2 Spike Glycoprotein LS-G145846 is a Recombinant Coronavirus SARS-CoV-2 Spike Glycoprotein produced in Mammalian Arg319-Pro589 with mFc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method).
Specifications
Type
Recombinant Protein
Target
SARS-CoV-2 Spike Glycoprotein
Synonyms
S / Spike Glycoprote | SARS-CoV-2 | SARS-Cov2 | COVID-19 | SARS-CoV2 (COVID-19) Spike
Species
Coronavirus SARS-CoV-2
Modifications
Unmodified
Conjugations
Unconjugated
Applications
- ELISA (1 mg/ml)
- Western blot (1 mg/ml)
Tag
mFc, C-terminus
Region
Arg319-Pro589
AA Sequence
RVQPTESIVR FPNITNLCPF GEVFNATRFA SVYAWNRKRI SNCVADYSVL YNSASFSTFK CYGVSPTKLN DLCFTNVYAD SFVIRGDEVR QIAPGQTGKI ADYNYKLPDD FTGCVIAWNS NNLDSKVGGN YNYLYRLFRK SNLKPFERDI STEIYQAGST PCNGVEGFNC YFPLQSYGFQ PTNGVGYQPY RVVVLSFELL HAPATVCGPK KSTNLVKNKC VNFNFNGLTG TGVLTESNKK FLPFQQFGRD IADTTDAVRD PQTLEILDIT PPRDCGCKPC ICTVPEVSSV FIFPPKPKDV LTITLTPKVT CVVVDISKDD PEVQFSWFVD DVEVHTAQTQ PREEQFNSTF RSVSELPIMH QDWLNGKEFK CRVNSAAFPA PIEKTISKTK GRPKAPQVYT IPPPKEQMAK DKVSLTCMIT DFFPEDITVE WQWNGQPAEN YKNTQPIMDT DGSYFVYSKL NVQKSNWEAG NTFTCSVLHE GLHNHHTEKS LSHSPGK
Expression System
Mammalian
Source Species
Human
Purification
Greater than 95% by SDS-PAGE
Bio-Activity
Not Tested
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
0.2 µm filtered solution of PBS, pH 7.4
Storage
Aliquot and store at -20°C to -80°C for one year. Avoid repeated freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About SARS-CoV-2 Spike Glycoprotein
Publications (0)
Customer Reviews (0)
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/26/2024
Date Requested: 11/26/2024
